Tenaya Therapeutics IncNASDAQ:TNYA
- LAST PRICE4.2500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.0000/ 2
- Ask / Lots6.8000/ 2
- Open / Previous Close0.0000 / 4.2500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TNYA |
|---|---|---|
| 09:32 ET | 4922 | 4.2839 |
| 09:36 ET | 50200 | 4.305 |
| 09:45 ET | 100 | 4.33 |
| 09:50 ET | 100 | 4.31 |
| 09:52 ET | 950 | 4.285 |
| 10:03 ET | 2600 | 4.3 |
| 10:06 ET | 300 | 4.315 |
| 10:08 ET | 290 | 4.315 |
| 10:10 ET | 461 | 4.3 |
| 10:12 ET | 500 | 4.285 |
| 10:14 ET | 100 | 4.285 |
| 10:15 ET | 320 | 4.3 |
| 10:17 ET | 448 | 4.295 |
| 10:21 ET | 100 | 4.3 |
| 10:28 ET | 1000 | 4.3 |
| 10:32 ET | 2787 | 4.301 |
| 10:33 ET | 200 | 4.3 |
| 10:42 ET | 400 | 4.3098 |
| 10:44 ET | 1942 | 4.25 |
| 10:51 ET | 200 | 4.27 |
| 11:02 ET | 1221 | 4.27 |
| 11:18 ET | 900 | 4.2799 |
| 11:22 ET | 1051 | 4.29 |
| 11:24 ET | 1666 | 4.295 |
| 11:26 ET | 250 | 4.3099 |
| 11:29 ET | 200 | 4.295 |
| 11:33 ET | 1322 | 4.27 |
| 11:42 ET | 200 | 4.29 |
| 11:45 ET | 746 | 4.29 |
| 11:47 ET | 837 | 4.2802 |
| 11:51 ET | 10200 | 4.28 |
| 11:54 ET | 26200 | 4.27 |
| 11:56 ET | 100 | 4.28 |
| 11:58 ET | 100 | 4.27 |
| 12:02 ET | 100 | 4.26 |
| 12:05 ET | 531 | 4.26 |
| 12:21 ET | 500 | 4.26 |
| 12:25 ET | 1267 | 4.27 |
| 12:34 ET | 100 | 4.26 |
| 12:36 ET | 763 | 4.26 |
| 12:38 ET | 500 | 4.2654 |
| 12:43 ET | 2262 | 4.26 |
| 12:48 ET | 100 | 4.261 |
| 12:50 ET | 3400 | 4.3 |
| 12:52 ET | 163 | 4.29 |
| 12:54 ET | 100 | 4.285 |
| 12:57 ET | 200 | 4.27 |
| 01:15 ET | 2280 | 4.27 |
| 01:21 ET | 2521 | 4.25 |
| 01:32 ET | 700 | 4.2568 |
| 01:33 ET | 824 | 4.25 |
| 01:39 ET | 300 | 4.25 |
| 01:42 ET | 200 | 4.24 |
| 01:50 ET | 278 | 4.2418 |
| 01:51 ET | 285 | 4.24 |
| 01:55 ET | 6510 | 4.2 |
| 01:57 ET | 1352 | 4.19 |
| 02:02 ET | 1124 | 4.17 |
| 02:04 ET | 300 | 4.1782 |
| 02:06 ET | 1500 | 4.15 |
| 02:08 ET | 8002 | 4.13 |
| 02:09 ET | 797 | 4.132 |
| 02:11 ET | 200 | 4.13 |
| 02:13 ET | 600 | 4.14 |
| 02:15 ET | 2689 | 4.15 |
| 02:20 ET | 600 | 4.13 |
| 02:22 ET | 100 | 4.145 |
| 02:24 ET | 100 | 4.145 |
| 02:26 ET | 100 | 4.145 |
| 02:27 ET | 1700 | 4.16 |
| 02:29 ET | 759 | 4.155 |
| 02:31 ET | 200 | 4.155 |
| 02:36 ET | 200 | 4.15 |
| 02:38 ET | 240 | 4.155 |
| 02:40 ET | 100 | 4.145 |
| 02:42 ET | 4056 | 4.151 |
| 02:44 ET | 200 | 4.155 |
| 02:45 ET | 100 | 4.155 |
| 02:49 ET | 300 | 4.17 |
| 02:51 ET | 958 | 4.175 |
| 02:54 ET | 100 | 4.18 |
| 02:56 ET | 100 | 4.185 |
| 03:00 ET | 500 | 4.186 |
| 03:02 ET | 200 | 4.189 |
| 03:03 ET | 2269 | 4.195 |
| 03:05 ET | 2496 | 4.208 |
| 03:07 ET | 779 | 4.22 |
| 03:09 ET | 150 | 4.2199 |
| 03:12 ET | 3250 | 4.2 |
| 03:14 ET | 600 | 4.21 |
| 03:20 ET | 100 | 4.21 |
| 03:21 ET | 100 | 4.22 |
| 03:23 ET | 513 | 4.22 |
| 03:27 ET | 1059 | 4.24 |
| 03:30 ET | 1466 | 4.24 |
| 03:32 ET | 386 | 4.25 |
| 03:34 ET | 2152 | 4.26 |
| 03:36 ET | 200 | 4.26 |
| 03:39 ET | 365 | 4.26 |
| 03:41 ET | 80511 | 4.24 |
| 03:43 ET | 3894 | 4.23 |
| 03:48 ET | 1687 | 4.24 |
| 03:50 ET | 300 | 4.25 |
| 03:52 ET | 200 | 4.25 |
| 03:54 ET | 1920 | 4.24 |
| 03:56 ET | 5220 | 4.23 |
| 03:57 ET | 5533 | 4.26 |
| 03:59 ET | 28439 | 4.25 |
Yesterday
DJ Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity, from 16 hours ago by Dow Jones
16 hours ago by Dow Jones
May 15, 2024
DJ Tenaya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 12:03PM ET on Wednesday May 15, 2024 by Dow Jones
12:03PM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
DJ Tenaya Therapeutics Cutting Workforce by 22%, from 5:17PM ET on Tuesday May 14, 2024 by Dow Jones
5:17PM ET on Tuesday May 14, 2024 by Dow JonesTenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
4:05PM ET on Tuesday May 14, 2024 by Dow JonesPress Release: Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
4:05PM ET on Tuesday May 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tenaya Therapeutics Inc | 333.7M | -2.6x | --- |
Inovio Pharmaceuticals Inc | 331.4M | -2.3x | --- |
Skye Bioscience Inc | 343.8M | -2.7x | --- |
Alto Neuroscience Inc | 344.7M | -9.0x | --- |
Erasca Inc | 320.7M | -2.2x | --- |
Fractyl Health Inc | 320.3M | -3.4x | --- |
Company Information
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. TN-401 is the Company’s adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC) due to disease-causing variants in the PKP2 gene. TN-301 is a small molecule for heart failure with preserved ejection fraction.
Contact Information
- Headquarters
- 171 Oyster Point Blvd., Suite 500SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 415-865-2066
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Goeddel
- Chief Executive Officer, Director
- Faraz Ali
- Chief Financial and Business Officer
- Leone Patterson
- Chief Scientific Officer
- Timothy Hoey
- Chief Medical Officer
- Whittemore Tingley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $333.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 78.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.65 |
Book Value | $2.04 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
